What Are Analysts Opinions On China Pharma Holdings, Inc. (CPHI)


China Pharma Holdings, Inc. (CPHI) will report its next earnings on Feb 14 BMO. The company reported the earnings of $0.08/Share in the last quarter where the estimated EPS by analysts was $0.12/share. The difference between the expected and actual EPS was $-0.04/share, which represents an Earnings surprise of -33.3%.

The Relative Volume of the company is 4.07 and Average Volume (3 months) is 1.06 million.

The company shows its Return on Assets (ROA) value of -11.5%. The Return on Equity (ROE) value stands at -15.3%. While it’s Return on Investment (ROI) value is -12.1%.

While looking at the Stock’s Performance, China Pharma Holdings, Inc. currently shows a Weekly Performance of 165.15%, where Monthly Performance is 178.37%, Quarterly performance is 210.65%, 6 Months performance is 133.33% and yearly performance percentage is 102.7%. Year to Date performance value (YTD perf) value is 198.97%. The Stock currently has a Weekly Volatility of 76.96% and Monthly Volatility of 24.43%.